NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/03/2023
Voltar para busca
Dado oficial do USPTO
HANCHORBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
21/03/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 42
Data de depósito
14/06/2021
Data de registro
21/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/03/2023
Última transação
21/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
16
Localização do titular
Taipei City, TW
Examinador
KUYKENDALL, LYNDSEY
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "HanchorBio" in stylized blue font below three interconnected designs comprised of three interconnected circular designs each, in bright blue, orange and light green. Beneath the interconnected circular design is a grey oval shadow.
Titulares e representantes
Titulares
HanchorBio Inc.
Representantes
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products and medicines for the treatment of cancers or autoimmune diseases for human use; Reagents for medical diagnostics; Therapeutic reagents for promoting hair growth; Vaccines for human use; Pharmaceutical reagents for medical useto enhance immunity; Anti-cancer reagents and medicines; Image-forming reagents for medical diagnostics; Western medicines for treating cancers or autoimmune diseases; Chinese medicines for treating cancers or autoimmune diseases; Anti-viral reagents and medicines for treating cancers or autoimmune diseases; Biological reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Protein reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Chemical reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Biological tissue culture reagents for medical therapeutic use for the treatment of cancers or autoimmune diseases; Testing chemicals for medical therapeutic use for the treatment of cancers or autoimmune diseases; Diagnostic reagents for medical therapeutic use; Biomarker diagnostic reagents for medical therapeutic use; Nutritional supplements; Biological reagents for veterinary use
Classe 35
retail and wholesale store services featuring pharmaceutical products; retail and wholesale store services featuring western medicines; retail and wholesale store services featuring Chinese medicines; retail and wholesale store services featuring nutritional supplements; retail and wholesale store services featuring medical equipment
Classe 42
Providing services for biomedical research and developmentproducing biological medicines; Biological research; Bacteriological research; Providing experimental medicines sample testing and diagnostic services for others for clinical research purposes; Providing reagent sample testing and diagnostic services for others for clinical research purposes; Clinical testing of pharmaceutical medicines for others; Scientific research and analysis of experimental medicines or reagents; Medical research; Product research and development on behalf of other parties; Technical research in the field of pharmaceutical studies; Research for technological programs in the nature of biological drug design; Technical writingwriting of technological documents; industrial analysis and research services; Rental of laboratory equipment for experiments; Service for scientific laboratories; Scientific research; Technological consultancy in the field of biological protein engineering; Scientific research in the field of biological/biomedical protein design and engineering; technical research in the field of biological/biomedical protein design and engineering
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
21/03/2023
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
19/01/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
17/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/01/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/01/2023
PUBO
PUBLISHED FOR OPPOSITION
03/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/12/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/11/2022
ALIE
ASSIGNED TO LIE
22/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/11/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
15/11/2022
DMCC
DATA MODIFICATION COMPLETED
15/11/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
13/10/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2022
ALIE
ASSIGNED TO LIE
04/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/03/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/03/2022
GNRT
NON-FINAL ACTION E-MAILED
08/03/2022
CNRT
NON-FINAL ACTION WRITTEN
08/03/2022
DOCK
ASSIGNED TO EXAMINER
03/03/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2021
NWAP
NEW APPLICATION ENTERED
17/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HANCHORBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.